Jazz Pharmaceuticals (JAZZ) Shares Outstanding (2010 - 2026)

Jazz Pharmaceuticals has reported Shares Outstanding for 17 years, with the latest figure at $4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding fell 93.51% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (down 93.51% YoY), and the FY2025 full-year result was $61.4 million, up 1.33% from the prior year.
• Shares Outstanding for Q1 2026 stood at $4.0 million, down from $61.4 million in the prior quarter.
• The five-year high for Shares Outstanding was $64.0 million in Q1 2023, with the low at $4.0 million in Q1 2022.
• Average Shares Outstanding over 5 years is $48.3 million, with a median of $61.4 million recorded in 2025.
• Peak annual rise in Shares Outstanding reached 1499.68% in 2023, while the deepest fall reached 93.67% in 2023.
• Tracing JAZZ's Shares Outstanding over 5 years: stood at $63.2 million in 2022, then slumped by 93.67% to $4.0 million in 2023, then soared by 1415.0% to $60.6 million in 2024, then climbed by 1.32% to $61.4 million in 2025, then plunged by 93.49% to $4.0 million in 2026.
• The last three Shares Outstanding figures came in at $4.0 million (Q1 2026), $61.4 million (Q4 2025), and $60.7 million (Q3 2025), per Business Quant data.

Peer Comparison